Stock Taper 
DMAA
$10.76
▲ UP 0.09% (0.01)
KEY STATISTICS
Market Cap$261.22 M
52w High$10.77
52w Low$10.23
Dividend Yield—
Frequency—
P/E53.80
Volume29.71K
Shares Out.24.28M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Roger Bendelac
ABOUT
SECTOR
Financial Services
WENT PUBLIC
January 27, 2025
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
2
PRICE
$10.76 ▲ UP 0.09% (+$0.01)About Drugs Made In America Acquisition Corp. Ordinary Shares
https://dmaacorp.com ↗Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
INDUSTRY
Shell Companies
ETFS HOLDING THIS STOCK
ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
77.98%
HOLDERS
46
TOP 12 OF 46 · RANKED BY POSITION SIZE
Karpus Management, Inc.
First Trust Capital Management L.P.
Mizuho Securities Usa LLC
Polar Asset Management Partners Inc.
Glazer Capital, LLC
Westchester Capital Management, LLC
Wolverine Asset Management LLC
Hudson Bay Capital Management LP
Highbridge Capital Management LLC
Aristeia Capital LLC
Mercuria Capital Strategies, LLC
D. E. Shaw & Co., Inc.
TACO
ALF
TACOU
TACH
OYSE
SIMA
RTAC